Herein, we present a case of ALK-positive lung adenocarcinoma in which the patient achieved extended survival after undergoing precise pleural effusion NGS and combined bevacizumab treatment following multiple-line ALK-TKI resistance. Here, ALK is linked to lung adenocarcinoma.